Maternal Medications and Human Milk Research Center (M2HMRC)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) is preparing to issue a Notice of Funding Opportunity (NOFO) to establish the Maternal Medication and Human Milk Research Center (M2HMRC) as a key component of the NICHD’s Maternal and Pediatric Precision in Therapeutics (MPRINT) Hub. This center will focus on advancing research into the effects of maternal medications on the composition of human milk and the health outcomes for neonates and infants. Its mission includes identifying knowledge gaps in medication use during pregnancy and lactation, integrating real-world evidence with chemical and bioanalytic data, developing innovative tools to enhance medication safety and efficacy, and broadly disseminating this knowledge. The M2HMRC will work collaboratively with MPRINT’s Knowledge and Research Coordinating Center to conduct clinical, translational, and data science research, all under a cooperative agreement framework suitable for complex, large-scale research activities. Currently, applications are not being solicited, but this announcement serves to provide advance notice, allowing potential applicants to build relevant collaborations and develop strong project proposals. The funding opportunity is authorized under several public health service acts and related laws, ensuring the NICHD’s ability to support this initiative. The point of contact for further information is Dr. Zhaoxia Ren, who can be reached via email or phone. This forecasted funding opportunity reflects the NIH’s commitment to improving maternal and pediatric health through precision therapeutics research.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications to establish a Maternal Medication and Human Milk Research Center (M2HMRC) as part of the NICHD’s Maternal and Pediatric Precision in Therapeutics (MPRINT) Hub. The M2HMRC will advance research on how maternal medications affect human milk composition and neonatal/infant health outcomes by: (1) Identifying critical knowledge gaps in medication use during pregnancy and lactation; (2) Integrating real-world evidence with chemical and bioanalytic data; (3) Developing innovative tools to improve medication safety and efficacy; and (4) Disseminating knowledge around medication use during lactation to a broad audience. The Center will collaborate with MPRINT’s Knowledge and Research Coordinating Center (KRCC) to conduct cutting-edge clinical, translational, and data science research. Applications are not being solicited at this time. Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. This NOFO will support cooperative agreements involving large-scale research activities with complex structures.
Grant authorities that allow the Eunice Kennedy Shriver National Institute of Child Health and Human Development to forecast this opportunity are as follows: Public Health Service Act, Section 301, 448 and 487, as amended, Public Laws 78-410 and 99-158, as amended, 42 U.S.C. 241; 42 U.S.C. 285g; 42 U.S.C. 288; Small Business Research and Development Enhancement Act of 1992, Public Law 102-564, Public Law 118-47.